Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Autoantibodies have been detected in sera before diagnosis of cancer leading to interest in their potential as screening/early detection biomarkers. As we have found autoantibodies to MUC1 glycopeptides to be elevated in early-stage breast cancer patients, in this study we analysed these autoantibodies in large population cohorts of sera taken before cancer diagnosis.
Original language | English |
---|---|
Journal | B J C |
Volume | 108 |
Issue number | 10 |
Pages (from-to) | 2045-55 |
Number of pages | 11 |
ISSN | 0007-0920 |
DOIs | |
Publication status | Published - 28 May 2013 |
ID: 47682907